Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine

Transplantation Reviews

Volumn 29, Issue 2, 2015, Pages 60-67

  Ong, Song ^a   Mannon, Roslyn B ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; PROTEIN;

ACUTE GRAFT REJECTION; AREA UNDER THE CURVE; BLOOD; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; GRAFT RECIPIENT; HUMAN; IMMUNOBIOLOGY; KIDNEY ALLOGRAFT; MOLECULAR DIAGNOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; URINE; ACUTE DISEASE; ADVERSE EFFECTS; GENETICS; GRAFT REJECTION; KIDNEY TRANSPLANTATION; METABOLISM;

ACUTE DISEASE; BIOMARKERS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MICRORNAS; PROTEINS; PROTEOMICS; RNA, MESSENGER;

EID: 84928203972     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.12.003     Document Type: Review

References (48)

1. Hariharan S., Kasiske B., Matas A., Cohen A., Harmon W., Rabb H. Surrogate markers for long-term renal allograft survival. Am J Transplant 2004, 4:1179-1183.
2. Williams W.W., Taheri D., Tolkoff-Rubin N., Colvin R.B. Clinical role of the renal transplant biopsy. Nat Rev Nephrol 2012, 8:110-121.
3. Furness P.N., Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int 2001, 60:1998-2012.
4. Li B., Hartono C., Ding R., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001, 344:947-954.
5. Muthukumar T., Ding R., Dadhania D., et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation 2003, 75:1565-1570.
6. Ding R., Li B., Muthukumar T., et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation 2003, 75:1307-1312.
7. Kotsch K., Mashreghi M.F., Bold G., et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004, 77:1866-1875.
8. Tatapudi R.R., Muthukumar T., Dadhania D., et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004, 65:2390-2397.
9. Muthukumar T., Dadhania D., Ding R., et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005, 353:2342-2351.
10. Seiler M., Brabcova I., Viklicky O., et al. Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant 2007, 7:423-433.
11. Renesto P.G., Ponciano V.C., Cenedeze M.A., Saraiva Camara N.O., Pacheco-Silva A. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 2007, 7:1661-1665.
12. Suthanthiran M., Schwartz J.E., Ding R., et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 2013, 369:20-31.
13. Matignon M., Ding R., Dadhania D.M., et al. Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol 2014, 25:1586-1597.
14. Ramachandran K., Saikumar J., Bijol V., et al. Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem 2013, 59:1742-1752.
15. Lorenzen J.M., Volkmann I., Fiedler J., et al. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant 2011, 11:2221-2227.
16. Maluf D.G., Dumur C.I., Suh J.L., et al. The urine microRNA profile may help monitor post-transplant renal graft function. Kidney Int 2014, 85:439-449.
17. Keslar K.S., Lin M., Zmijewska A.A., et al. Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling. Am J Transplant 2013, 13:1891-1897.
18. Vasconcellos L.M., Schachter A.D., Zheng X.X., et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998, 66:562-566.
19. Dugre F.J., Gaudreau S., Belles-Isles M., Houde I., Roy R. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection. Transplantation 2000, 70:1074-1080.
20. Shoker A., George D., Yang H., Baltzan M. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. Transplantation 2000, 70:497-505.
21. Luo Y., Shi B., Qian Y., Bai H., Chang J. Sequential monitoring of TIM-3 gene expression in peripheral blood for diagnostic and prognostic evaluation of acute rejection in renal graft recipients. Transplant Proc 2011, 43:3669-3674.
22. Garcia Moreira V., Prieto Garcia B., Baltar Martin J.M., Ortega Suarez F., Alvarez F.V. Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clin Chem 2009, 55:1958-1966.
23. Beck J., Bierau S., Balzer S., et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem 2013, 59:1732-1741.
24. Flechner S.M., Kurian S.M., Head S.R., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004, 4:1475-1489.
25. Li L., Khatri P., Sigdel T.K., et al. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 2012, 12:2710-2718.
26. Li L., Khush K., Hsieh S.C., et al. Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection. PLoS One 2013, 8:e82153.
27. Kurian S.M., Williams A.N., Gelbart T., et al. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant 2014, 14:1164-1172.
28. Khatri P., Roedder S., Kimura N., et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med 2013, 210:2205-2221.
29. Grigoryev Y.A., Kurian S.M., Avnur Z., et al. Deconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells. PLoS One 2010, 5:e13358.
30. Sui W., Dai Y., Huang Y., Lan H., Yan Q., Huang H. Microarray analysis of microRNA expression in acute rejection after renal transplantation. Transpl Immunol 2008, 19:81-85.
31. Anglicheau D., Sharma V.K., Ding R., et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 2009, 106:5330-5335.
32. Betts G., Shankar S., Sherston S., Friend P., Wood K.J. Examination of serum miRNA levels in kidney transplant recipients with acute rejection. Transplantation 2014, 97:e28-e30.
33. Grigoryev Y.A., Kurian S.M., Hart T., et al. MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol 2011, 187:2233-2243.
34. Danger R., Pallier A., Giral M., et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012, 23:597-606.
35. Danger R., Paul C., Giral M., et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One 2013, 8:e60702.
36. Srivastava M., Eidelman O., Torosyan Y., Jozwik C., Mannon R.B., Pollard H.B. Elevated expression levels of ANXA11, integrins beta3 and alpha3, and TNF-alpha contribute to a candidate proteomic signature in urine for kidney allograft rejection. Proteomics Clin Appl 2011, 5:311-321.
37. Hu H., Kwun J., Aizenstein B.D., Knechtle S.J. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation 2009, 87:1814-1820.
38. Schaub S., Nickerson P., Rush D., et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant 2009, 9:1347-1353.
39. Ho J., Rush D.N., Karpinski M., et al. Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis. Transplantation 2011, 92:878-882.
40. Jackson J.A., Kim E.J., Begley B., et al. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant 2011, 11:2228-2234.
41. Hirt-Minkowski P., Amico P., Ho J., et al. Detection of clinical and subclinical tubulo-interstitial inflammation by the urinary CXCL10 chemokine in a real-life setting. Am J Transplant 2012, 12:1811-1823.
42. Hricik D.E., Nickerson P., Formica R.N., et al. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant 2013, 13:2634-2644.
43. Sigdel T.K., Kaushal A., Gritsenko M., et al. Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl 2010, 4:32-47.
44. Ling X.B., Sigdel T.K., Lau K., et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol 2010, 21:646-653.
45. Sigdel T.K., Salomonis N., Nicora C.D., et al. The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics. Mol Cell Proteomics 2014, 13:621-631.
46. Freue G.V., Sasaki M., Meredith A., et al. Proteomic signatures in plasma during early acute renal allograft rejection. Mol Cell Proteomics 2010, 9:1954-1967.
47. Wu D., Zhu D., Xu M., et al. Analysis of transcriptional factors and regulation networks in patients with acute renal allograft rejection. J Proteome Res 2011, 10:175-181.
48. Xu X., Huang H., Cai M., et al. Combination of IL-1 receptor antagonist, IL-20 and CD40 ligand for the prediction of acute cellular renal allograft rejection. J Clin Immunol 2013, 33:280-287.